Prot #X052130/CL3-78989-005: A RandomizEd, Double-masked, Placebo-controlled Study of the SafetY and Efficacy of GevokizUmAb in the TReatment of Active Non-infectious IntermeDiate, Posterior, or Pan- Uveitis

Project: Research project

Project Details

StatusFinished
Effective start/end date1/29/131/29/16

Funding

  • JANIX BioSciences, LLC (Prot #X052130/CL3-78989-005 // Prot #X052130/CL3-78989-005)
  • XOMA Corporation (Prot #X052130/CL3-78989-005 // Prot #X052130/CL3-78989-005)